Silo Pharma, Inc. was notified on June 27, 2025, that it is not meeting the minimum bid price requirement of $1.00 per share to remain listed on Nasdaq, having a bid price below the requirement since May 14, 2025. They have until December 24, 2025, to regain compliance, possibly considering a reverse stock split if necessary.